{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:07:06Z","timestamp":1772136426756,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["101024833"],"award-info":[{"award-number":["101024833"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["452020104"],"award-info":[{"award-number":["452020104"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["FLF105666"],"award-info":[{"award-number":["FLF105666"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2025266"],"award-info":[{"award-number":["GNT2025266"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce chronic kidney disease progression in people with type 2 diabetes mellitus. Sepsis is the leading cause of acute kidney injury (AKI). This study investigated whether GLP-1 is renoprotective in an ovine model of gram-negative septic AKI. Sixteen healthy merino ewes were surgically instrumented to measure mean arterial pressure, cardiac output, renal blood flow, renal cortical and medullary perfusion and oxygenation, and renal function. After a 5-day recovery period, sepsis was induced via continuous intravenous infusion of live\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    for 30\u00a0h. After 24\u00a0h, the sheep were randomized to receive an intravenous infusion of 3.6 pmol\/kg\/min GLP-1 (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098) or a fluid-matched vehicle (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098) for 6\u00a0h. After 24\u00a0h of sepsis, 7\/8 sheep in each group developed AKI. GLP-1 treatment increased renal blood flow compared to placebo\u2009+\u200913 vs. \u2212 3.4\u00a0ml\/min difference (95% CI)\u2009=\u200916 (\u2212 7\u201340)\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.0054), and maintained renal cortical oxygenation\u2009+\u20092.5 mmHg vs. = \u2212 7.2 mmHg, difference (95% CI)\u2009=\u20099.7 (5.2\u201314.4)\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001. GLP-1 maintained renal medullary perfusion\u2009+\u20091.7 vs. vehicle \u2212\u2009213 perfusion units, difference (95% CI)\u2009=\u2009214 (\u2212 21\u2013450)\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.07. However, GLP-1 did not significantly improve the primary endpoint of renal medullary oxygenation \u2212\u20091.6 vs. \u2212 11.5, difference (95% CI)\u2009=\u20099.9 (\u2212 6.8\u201326.7)\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.21. In an ovine model of gram-negative sepsis-associated AKI, GLP-1 infusion supported global renal perfusion, renal oxygen delivery, and cortical oxygenation but failed to improve renal medullary oxygenation and kidney function.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-33109-0","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T17:15:41Z","timestamp":1766596541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of glucagon-like peptide-1 on systemic hemodynamics, kidney function, and intrarenal oxygenation in sheep with sepsis-associated acute kidney injury"],"prefix":"10.1038","volume":"16","author":[{"given":"Abraham H.","family":"Hulst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie P. C.","family":"Ow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive N.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally G.","family":"Hood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Hermanides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl H.","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M.","family":"Deane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugeesh R.","family":"Lankadeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"33109_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste, E. A. J. et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 41, 1411\u20131423 (2015).","journal-title":"Intensive Care Med."},{"key":"33109_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana, S., Manrique-Caballero, C. L., G\u00f3mez, H. & Kellum, J. A. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 96, 1083\u20131099 (2019).","journal-title":"Kidney Int."},{"key":"33109_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-017-0260-y","volume":"7","author":"R Bellomo","year":"2017","unstructured":"Bellomo, R. et al. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris international conference. Ann. Intensive Care. 7, 1\u201340 (2017).","journal-title":"Ann. Intensive Care"},{"key":"33109_CR4","first-page":"588","volume":"20","author":"A Zarbock","year":"2014","unstructured":"Zarbock, A., Gomez, H. & Kellum, J. A. Sepsis-induced acute kidney injury revisited: Pathophysiology, prevention and future therapies. Curr. Opin. Crit. Care. 20, 588\u2013595 (2014).","journal-title":"Curr. Opin. Crit. Care"},{"key":"33109_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/CCM.0000000000003023","volume":"46","author":"A Schuler","year":"2018","unstructured":"Schuler, A. et al. The impact of acute organ dysfunction on long-term survival in sepsis. Crit. Care Med. 46, 843\u2013849 (2018).","journal-title":"Crit. Care Med."},{"key":"33109_CR6","doi-asserted-by":"crossref","unstructured":"Poston, J. T. & Koyner, J. L. Sepsis associated acute kidney injury. BMJ. 364, (2019).","DOI":"10.1136\/bmj.k4891"},{"key":"33109_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","volume":"43","author":"M Joannidis","year":"2017","unstructured":"Joannidis, M. et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on Prevention, AKI section, European society of intensive care medicine. Intensive Care Med. 43, 730\u2013749 (2017).","journal-title":"Intensive Care Med."},{"key":"33109_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","volume":"13","author":"SV Badve","year":"2025","unstructured":"Badve, S. V. et al. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 13, 15\u201328 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"33109_CR9","doi-asserted-by":"crossref","unstructured":"Haddock, B. et al. GLP\u2009\u2013\u20091 promotes cortical and medullary perfusion in the human kidney and maintains renal oxygenation during NaCl loading. J Am. Heart Assoc. 12, (2023).","DOI":"10.1161\/JAHA.122.027712"},{"key":"33109_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2197-4","volume":"22","author":"AH Hulst","year":"2018","unstructured":"Hulst, A. H. et al. Systematic review of incretin therapy during peri-operative and intensive care. Crit. Care. 22, 1\u201312 (2018).","journal-title":"Crit. Care"},{"key":"33109_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.semnephrol.2019.10.004","volume":"39","author":"YR Lankadeva","year":"2019","unstructured":"Lankadeva, Y. R., Okazaki, N., Evans, R. G., Bellomo, R. & May, C. N. Renal medullary hypoxia: A new therapeutic target for septic acute kidney injury? Semin. Nephrol. 39, 543\u2013553 (2019).","journal-title":"Semin. Nephrol."},{"key":"33109_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.kint.2016.02.017","volume":"90","author":"YR Lankadeva","year":"2016","unstructured":"Lankadeva, Y. R. et al. Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury. Kidney Int. 90, 100\u2013108 (2016).","journal-title":"Kidney Int."},{"key":"33109_CR13","doi-asserted-by":"crossref","unstructured":"Betrie, A. H. et al. Renal arterial infusion of tempol prevents medullary hypoperfusion, hypoxia, and acute kidney injury in ovine Gram-negative sepsis. Acta Physiol. 239, (2023).","DOI":"10.1111\/apha.14025"},{"key":"33109_CR14","first-page":"1","volume":"18","author":"NP du Sert","year":"2020","unstructured":"du Sert, N. P. et al. The arrive guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 18, 1\u201312 (2020).","journal-title":"PLoS Biol."},{"key":"33109_CR15","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1097\/CCM.0000000000002797","volume":"46","author":"YR Lankadeva","year":"2018","unstructured":"Lankadeva, Y. R., Kosaka, J., Evans, R. G., Bellomo, R. & May, C. N. Urinary oxygenation as a surrogate measure of medullary oxygenation during angiotensin II therapy in septic acute kidney injury. Crit. Care Med. 46, e41\u2013e48 (2018).","journal-title":"Crit. Care Med."},{"key":"33109_CR16","doi-asserted-by":"publisher","first-page":"R232","DOI":"10.1152\/ajpregu.00371.2018","volume":"317","author":"N Iguchi","year":"2019","unstructured":"Iguchi, N. et al. Furosemide reverses medullary tissue hypoxia in ovine septic acute kidney injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 317, R232\u2013R239 (2019).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"33109_CR17","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/sj.ki.5000440","volume":"69","author":"C Langenberg","year":"2006","unstructured":"Langenberg, C., Wan, L., Egi, M., May, C. N. & Bellomo, R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 69, 1996\u20132002 (2006).","journal-title":"Kidney Int."},{"key":"33109_CR18","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1097\/CCM.0000000000003507","volume":"47","author":"YR Lankadeva","year":"2019","unstructured":"Lankadeva, Y. R. et al. Effects of fluid bolus therapy on renal Perfusion, Oxygenation, and function in early experimental septic kidney injury. Crit. Care Med. 47, E36\u2013E43 (2019).","journal-title":"Crit. Care Med."},{"key":"33109_CR19","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.kint.2019.06.013","volume":"96","author":"YR Lankadeva","year":"2019","unstructured":"Lankadeva, Y. R. et al. Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury. Kidney Int. 96, 1150\u20131161 (2019).","journal-title":"Kidney Int."},{"key":"33109_CR20","doi-asserted-by":"publisher","first-page":"E951","DOI":"10.1097\/CCM.0000000000004511","volume":"48","author":"N Okazaki","year":"2020","unstructured":"Okazaki, N. et al. Beneficial effects of vasopressin compared with norepinephrine on renal Perfusion, Oxygenation, and function in experimental septic acute kidney injury. Crit. Care Med. 48, E951\u2013E958 (2020).","journal-title":"Crit. Care Med."},{"key":"33109_CR21","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1097\/CCM.0000000000000963","volume":"43","author":"YR Lankadeva","year":"2015","unstructured":"Lankadeva, Y. R. et al. Clonidine restores pressor responsiveness to phenylephrine and angiotensin II in ovine sepsis. Crit. Care Med. 43, e221\u2013e229 (2015).","journal-title":"Crit. Care Med."},{"key":"33109_CR22","doi-asserted-by":"publisher","first-page":"R832","DOI":"10.1152\/ajpregu.00515.2014","volume":"308","author":"P Calzavacca","year":"2015","unstructured":"Calzavacca, P. et al. Long-term measurement of renal cortical and medullary tissue oxygenation and perfusion in unanesthetized sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308, R832\u2013R839 (2015).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"33109_CR23","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1097\/CCM.0000000000004770","volume":"49","author":"YR Lankadeva","year":"2021","unstructured":"Lankadeva, Y. R. et al. Reversal of the pathophysiological responses to Gram-Negative sepsis by megadose vitamin C. Crit. Care Med. 49, e179\u2013e190 (2021).","journal-title":"Crit. Care Med."},{"key":"33109_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jclinepi.2006.02.007","volume":"59","author":"GJ Van Breukelen","year":"2006","unstructured":"Van Breukelen, G. J. P. ANCOVA versus change from baseline had more power in randomized studies and more bias in nonrandomized studies. J. Clin. Epidemiol. 59, 920\u2013925 (2006).","journal-title":"J. Clin. Epidemiol."},{"key":"33109_CR25","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010006","volume":"26","author":"MA Venkatachalam","year":"2015","unstructured":"Venkatachalam, M. A., Weinberg, J. M., Kriz, W. & Bidani, A. K. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J. Am. Soc. Nephrol. 26, 1765\u20131776 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33109_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/17450397809421008","volume":"28","author":"M Ulbrich","year":"1978","unstructured":"Ulbrich, M., Nienke, U. & Hakim, N. F. Glucose content of lambs\u2019 blood. 1. Effect of administration of various carbohydrates. Arch. Tierernahr. 28, 673\u2013677 (1978).","journal-title":"Arch. Tierernahr."},{"key":"33109_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1071\/AR9500182","volume":"1","author":"R Reid","year":"1950","unstructured":"Reid, R. Studies on the carbohydrate metabolism of sheep. I. The range of blood-sugar values under several conditions. Aust. J. Agric. Res. 1, 182 (1950).","journal-title":"Aust. J. Agric. Res."},{"key":"33109_CR28","doi-asserted-by":"crossref","unstructured":"Pan, H. C. et al. GLP-1 receptor agonists\u2019 impact on cardio-renal outcomes and mortality in T2D with acute kidney disease. Nat. Commun. 15, (2024).","DOI":"10.1038\/s41467-024-50199-y"},{"key":"33109_CR29","doi-asserted-by":"crossref","unstructured":"Begum, F. et al. Semaglutide-associated kidney injury. Clin. Kidney J. 17, (2024).","DOI":"10.1093\/ckj\/sfae250"},{"key":"33109_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1152\/ajprenal.00394.2015","volume":"310","author":"LXS Farah","year":"2016","unstructured":"Farah, L. X. S. et al. The physiological role of glucagon-like peptide-1 in the regulation of renal function. Am. J. Physiol. Ren. Physiol. 310, 123\u2013127 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"33109_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1152\/ajprenal.00527.2014","volume":"308","author":"EP Jensen","year":"2015","unstructured":"Jensen, E. P. et al. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow. Am. J. Physiol. Ren. Physiol. 308, 867\u2013877 (2015).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"33109_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/CH-242296","volume":"88","author":"R Chen","year":"2024","unstructured":"Chen, R., Liu, D., Zhao, H. & Wang, X. Renal medullary perfusion differs from that in renal cortex in patients with sepsis associated acute kidney injury and correlates with renal function prognosis: A prospective cohort study. Clin. Hemorheol. Microcirc. 88, 181\u2013198 (2024).","journal-title":"Clin. Hemorheol. Microcirc"},{"key":"33109_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-016-0490-6","volume":"16","author":"M Lorenz","year":"2017","unstructured":"Lorenz, M. et al. Differential effects of glucagon-like peptide-1 receptor agonists on heart rate. Cardiovasc. Diabetol. 16, 6 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"33109_CR34","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/cvr\/cvae120","volume":"120","author":"AF Lubberding","year":"2024","unstructured":"Lubberding, A. F. et al. Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node. Cardiovasc. Res. 120, 1427\u20131441 (2024).","journal-title":"Cardiovasc. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33109-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T14:04:46Z","timestamp":1769177086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33109"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33109-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7445170\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Animal Ethics Committee of the Florey Institute of Neuroscience and Mental Health (Ethics identification number: 21-030-FINMH) approved these experiments under the guidelines of the National Health and Medical Research Council of Australia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"3250"}}